Dupilumab for atopic dermatitis in metastatic cancer

被引:3
作者
McClatchy, Jessica [1 ]
Ross, Gayle [1 ,2 ]
机构
[1] Royal Melbourne Hosp, Dept Dermatol, 300 Grattan St, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Australia
关键词
atopic dermatitis; check point inhibitor; Dupilumab; malignancy;
D O I
10.1111/ajd.14296
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
We present a case of a 47-year-old male with severe atopic dermatitis and metastatic renal cell carcinoma managed successfully with dupilumab. This case further supports the safety of dupilumab in patients with active malignancy, an area currently with limited data.
引用
收藏
页码:472 / 475
页数:4
相关论文
共 10 条
[1]   Expert consensus on the systemic treatment of atopic dermatitis in special populations [J].
Adam, D. N. ;
Gooderham, M. J. ;
Beecker, J. R. ;
Hong, C. H. ;
Jack, C. S. ;
Jain, V. ;
Lansang, P. ;
Lynde, C. W. ;
Papp, K. A. ;
Prajapati, V. H. ;
Turchin, I. ;
Yeung, J. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (06) :1135-1148
[2]   Engineering the IL-4/IL-13 axis for targeted immune modulation [J].
Bernstein, Zachary J. J. ;
Shenoy, Anjali ;
Chen, Amy ;
Heller, Nicola M. M. ;
Spangler, Jamie B. B. .
IMMUNOLOGICAL REVIEWS, 2023, 320 (01) :29-57
[3]   Dupilumab as a treatment for cutaneous immune-related adverse events induced by immune checkpoint inhibitors: A case series and review of the literature [J].
Fournier, Cynthia ;
Hirsch, Ian ;
Spreafico, Anna ;
Butler, Marcus Otho ;
Dhani, Neesha ;
Sauder, Maxwell Benjamin .
SAGE OPEN MEDICAL CASE REPORTS, 2023, 11
[4]   Two Cancer Patients Receiving Dupilumab for Treatment of Atopic Dermatitis [J].
Fowler, Emilie ;
Rosen, Jordan ;
Lev-Tov, Hadar ;
Yosipovitch, Gil .
ACTA DERMATO-VENEREOLOGICA, 2019, 99 (10) :899-900
[5]   Management of immune-related cutaneous adverse events with dupilumab [J].
Kuo, Alyce Mei-Shiuan ;
Gu, Stephanie ;
Stoll, Joseph ;
Moy, Andrea P. ;
Dusza, Stephen W. ;
Gordon, Allison ;
Haliasos, Elena C. ;
Janjigian, Yelena ;
Kraehenbuehl, Lukas ;
Quigley, Elizabeth A. ;
Chapman, Paul ;
Lacouture, Mario E. ;
Markova, Alina .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (06)
[6]   No association between dupilumab use and short-term cancer development in atopic dermatitis patients [J].
Owji, Shayan ;
Ungar, Benjamin ;
Dubin, Danielle P. ;
Poplausky, Dina ;
Young, Jade N. ;
Ghalili, Sabrina ;
Han, Joseph ;
Srinivasan, Dhipthika ;
Packer, Sarah ;
Pavel, Ana B. ;
da Rosa, Joel Correa ;
Guttman-Yassky, Emma ;
Gulati, Nicholas .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (05) :1548-1551
[7]   Cutaneous T-cell lymphoma following dupilumab use: a systematic review [J].
Park, Ariel ;
Wong, Lulu ;
Lang, Annalise ;
Kraus, Christina ;
Anderson, Nancy ;
Elsensohn, Ashley .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2023, 62 (07) :862-876
[8]   Cutaneous adverse events caused by immune checkpoint inhibitors [J].
Quach, Henry T. ;
Johnson, Douglas B. ;
LeBoeuf, Nicole R. ;
Zwerner, Jeffrey P. ;
Dewan, Anna K. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (04) :956-966
[9]   Atopic dermatitis, dupilumab and cancers: a case series [J].
Siliquini, N. ;
Giura, M. T. ;
Viola, R. ;
Ribero, S. ;
Panzone, M. ;
Dapavo, P. ;
Fierro, M. T. ;
Ortoncelli, M. ;
Quaglino, P. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (10) :E651-E652
[10]   Treatment of Severe Atopic Dermatitis with Dupilumab in Patients with Advanced Cancer [J].
Tanczosova, Milena ;
Hugo, Jan ;
Gkalpakiotis, Spyridon .
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (03)